Camrelizumab Has Activity in Patients With Nasopharyngeal Carcinoma

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-rw2018-161
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

Treatment Results and Prognostic Factors in 73 Patients With Nasopharyngeal Carcinoma.

Japanese jornal of Head and Neck Cancer
1997English

Identify the Radiotherapy-Induced Abnormal Changes in the Patients With Nasopharyngeal Carcinoma

ADMET and DMPK
PharmacologyHealthMedicineToxicologyChemistryPharmaceutics
2017English

Parsaclisib Has Activity in Patients With B-Cell Malignancies

Cancer Discovery
Oncology
2019English

Vemurafenib Has Activity in Patients With BRAFV600-Mutant Glioma

Cancer Discovery
Oncology
2018English

Combination Treatment With Cetuximab in Advanced Nasopharyngeal Carcinoma Patients: A Meta-Analysis

OncoTargets and Therapy
OncologyPharmacology
2019English

Effects of Radiation Therapy on Neuropsychological Functioning in Patients With Nasopharyngeal Carcinoma.

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1989English

Distinctive microRNA Expression in Early Stage Nasopharyngeal Carcinoma Patients

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2016English

Nasopharyngeal Carcinoma

2019English

Nasopharyngeal Carcinoma

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy